Filing Flows › Kestra Medical Technologies (KMTS) › Recalls, complaints & regulation

Kestra Medical Technologies (KMTS): clinical trials

Kestra Medical Technologies (KMTS) beyond its filings: 1 active clinical trial.

Kestra Medical Technologies' latest quarter

Kestra Medical Technologies, Q1 FY27: revenue $31.0M (+60% year over year), operating margin -121.6%, net loss $44.1M, operating cash flow −$32.3M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Kestra Medical Technologies have?

1 active study on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.